A bilayer construct controls adipose-derived stem cell differentiation into endothelial cells and pericytes without growth factor stimulation.
Natesan S., Zhang G., Baer DG., Walters TJ., Christy RJ., Suggs LJ.
Animal Study on Burns, published in Tissue Eng Part A (2011) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Tissue Eng Part A (2011)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 21083419
- PMCID
- PMC3117235
- DOI
- 10.1089/ten.TEA.2010.0294
- Citations
- 50
Abstract (original English)
This work describes the differentiation of adipose-derived mesenchymal stem cells (ASC) in a composite hydrogel for use as a vascularized dermal matrix. Our intent is that such a construct could be utilized following large-surface-area burn wounds that require extensive skin grafting and that are limited by the availability of uninjured sites. To develop engineered skin replacement constructs, we are pursuing the use of ASC. We have established that a PEGylated fibrin gel can provide a suitable environment for the proliferation of ASC over a 7 day time course. Further, we have demonstrated that PEGylated fibrin can be used to control ASC differentiation toward vascular cell types, including cells characteristic of both endothelial cells and pericytes. Gene expression analysis revealed strong upregulation of endothelial markers, CD31, and von Willebrand factor, up to day 11 in culture with corresponding evidence of protein expression demonstrated by immunocytochemical staining. ASC were not only shown to express endothelial cell phenotype, but a subset of the ASC expressed pericyte markers. The NG2 gene was upregulated over 11 days with corresponding evidence for the cell surface marker. Platelet-derived growth factor receptor beta gene expression decreased as the multipotent ASC differentiated up to day 7. Increased receptor expression at day 11 was likely due to the enhanced p
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Platelet-rich plasma and ablative fractional carbon dioxide laser therapy for chronic scar management: a systematic review
Systematic Review with a reported sample of 420 on Burns, Scar, published in Lasers Med Sci (2026) — summary generated from the PubMed abstract.
- 2026
- n = 420
Lasers Med Sci - Level ASystematic ReviewEurope PMC
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Plant-Derived Nanovesicles as Cell-Free Therapies for Thermal Burn Healing: A Systematic Review of Preclinical Evidence and Delivery Strategies
Systematic Review on Chronic Wound, Burns, Scar, Chronic Inflammation, published in Med Sci (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Med Sci (Basel) - Level ASystematic ReviewPubMed
Autologous Nanofat Indications in Wound Healing: A Systematic Review.
Systematic Review with a reported sample of 3 on Chronic Wound, Burns, Scar, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3
Biomedicines - Level AMeta-analysisEurope PMC
Systematic review and meta-analysis of the use of micrografting technology in humans
Meta-analysis with a reported sample of 24 on Chronic Wound, Burns, Hair Loss, published in J Int Med Res (2025) — summary generated from the PubMed abstract.
- 2025
- n = 24
J Int Med Res1 citations - Level ASystematic ReviewPubMed
Encapsulation of Adipose-Derived Stem Cells in Collagen-Based Hydrogel: Regenerative Therapy for Burn Wound Healing.
Systematic Review on Chronic Wound, Burns, Scar, published in Ann Plast Surg (2025) — summary generated from the PubMed abstract.
- 2025
Ann Plast Surg - Level AMeta-analysisEurope PMC
Synergistic effects of mesenchymal stem cells and their secretomes with scaffolds in burn wound healing: a systematic review and meta-analysis of preclinical studies
Meta-analysis on Chronic Wound, Burns, Scar, Chronic Inflammation, published in J Transl Med (2025) — summary generated from the PubMed abstract.
- 2025
J Transl Med11 citations